[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-356779-105":59,"doc-detail-356779-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","bridging-biomaterials-and-immunotherapy-hydrogel-strategies-for-next-generation-car-t-cell-treatment","Bridging biomaterials and immunotherapy - hydrogel strategies for next-generation CAR-T cell treatment","","Breast cancer remains a leading cause of cancer-associated mortality worldwide, with rising incidence among younger women in developing regions and immigrant populations. Despite progress in diagnostics and targeted therapies, effective and less toxic options are still needed. CAR-T cell therapy harnesses the immune system, yet solid-tumor potential is limited. Hydrogel-based biomaterials offer local immune modulation, sustained cytokine delivery, and improved T-cell activation in the tumor microenvironment. Bridging materials science and tumor immunology may enhance antitumor responses while improving precision and safety.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/bridging-biomaterials-and-immunotherapy-hydrogel-strategies-for-next-generation-car-t-cell-treatment/356779/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/bridging-biomaterials-and-immunotherapy-hydrogel-strategies-for-next-generation-car-t-cell-treatment/356779.png","ImageObject",300,407,{"name":92,"@type":93},"Rizky","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-16","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is breast cancer treatment still challenging despite advances in diagnostics and targeted therapies?","Question",{"text":112,"@type":113},"Conventional therapies often fail in advanced or metastatic disease, and triple-negative breast cancer lacks actionable molecular targets while resistance emerges rapidly. The immunologically “cold” tumor microenvironment further limits immunotherapy success.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What main barriers reduce CAR-T cell efficacy in solid tumors such as breast cancer?",{"text":117,"@type":113},"Key challenges include poor T-cell trafficking and retention, antigen heterogeneity, and a highly suppressive tumor microenvironment that promotes exhaustion and dysfunction. Systemic delivery can also cause significant toxicities.",{"name":119,"@type":110,"acceptedAnswer":120},"How can hydrogel-based biomaterials support CAR-T therapy in the tumor microenvironment?",{"text":121,"@type":113},"Injectable hydrogels can create a supportive local microenvironment for CAR-T cells, enhancing survival, expansion, and effector function. They can also shield cells from hostile elements and enable controlled, site-specific delivery of cells, cytokines, or immunomodulatory compounds.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},356779,1790252092,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":46,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":31,"preview_page_count":19,"preview_urls":144},962085564807,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Shojaei etal. Stem Cell Research & Therapy (2026) 17:181 [https://doi.org/10.1186/s13287-026-04993-8](https://doi.org/10.1186/s13287-026-04993-8)  \nStem Cell Research & Therapy  \nREVIEW Open Access  \nBridging biomaterials and immunotherapy: hydrogel strategies for next-generation CAR-T cell treatment  \nShayda Shojaei1, Mahsa Sani1,2, Negar Azarpira1,3, Mona Latifi4 and Farnaz Sani2*  \nAbstract  \nBreast cancer remains a leading cause of cancer-associated mortality worldwide, with an increasing incidence among younger women, particularly in developing regions and immigrant populations. Although advances in diagnostics and targeted therapies have improved patient outcomes, the search for more effective and less toxic treatments continues. Chimeric antigen receptor (CAR) T-cell therapy has transformed cancer immunotherapy by harnessing the body’s own immune system to fight malignancy, yet its full potential in solid tumors is still being realized. Meanwhile, hydrogel-based biomaterials have emerged as versatile platforms capable of local immune modulation, sustained cytokine delivery, and enhanced T-cell activation within the tumor microenvironment. By bridging materials science with tumor immunology, this evolving field offers a new perspective on how to direct immune activity precisely where it is needed. Combining hydrogel technology with CAR-T cell therapy represents a promising strategy to strengthen antitumor responses and improve treatment precision and safety.  \nKeywords Breast cancer, CAR-T cell therapy, Hydrogel therapy, Immunosuppressive tumor microenvironment, On-target/off-tumor toxicity  \n*Correspondence:  \nFarnaz Sani  \n[Sani_Farnaz@yahoo.com](Sani_Farnaz@yahoo.com)  \n1Shiraz Institute for Stem Cell and Regenerative Medicine, Shiraz University of Medical Sciences, Shiraz, Iran  \n2Department of Tissue Engineering and Applied Cell Sciences, School of Advanced Medical Sciences and Technologies, Shiraz Institute for Stem Cell and Regenerative Medicine, Shiraz University of Medical Sciences, Shiraz, Iran  \n3Transplant Research Center, Shiraz University of Medical Sciences, Khalili Street, P. O. Box: 7193711351, Shiraz, Iran  \n4Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT 84112, USA  \nIntroduction  \nWith over 2.3 million new cases and about 700,000 deaths annually, breast cancer stands as both the most diagnosed malignancy and one of the leading causes of cancer-related mortality in women worldwide, underscoring its persistent global health burden [1, 2]. Although significant progress has been made in screening, surgery, chemotherapy, radiotherapy, and targeted agents; conventional treatments often fail in advanced or metastatic disease [3, 4]. Particularly in triple-negative breast cancer (TNBC), treatment options are limited due to the absence of actionable molecular targets and the rapid emergence of therapeutic resistance [5, 6]. Moreover, the immunologically “cold” nature of breast cancer, characterized by low T cell infiltration and high immunosuppression, further limits the success of immune checkpoint inhibitors and other standard immunotherapies [7].  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not","cbCaifGivPWNvsDx","https://ap.wps.com/l/cbCaifGivPWNvsDx","pdf",3618185,"English","# Abstract\n# Introduction\n## Breast cancer burden and treatment limitations\n## Immunologically cold tumor microenvironment\n## CAR-T cell therapy challenges in solid tumors\n# Biomaterial and hydrogel strategies","[{\"question\":\"Why is breast cancer treatment still challenging despite advances in diagnostics and targeted therapies?\",\"answer\":\"Conventional therapies often fail in advanced or metastatic disease, and triple-negative breast cancer lacks actionable molecular targets while resistance emerges rapidly. The immunologically “cold” tumor microenvironment further limits immunotherapy success.\"},{\"question\":\"What main barriers reduce CAR-T cell efficacy in solid tumors such as breast cancer?\",\"answer\":\"Key challenges include poor T-cell trafficking and retention, antigen heterogeneity, and a highly suppressive tumor microenvironment that promotes exhaustion and dysfunction. Systemic delivery can also cause significant toxicities.\"},{\"question\":\"How can hydrogel-based biomaterials support CAR-T therapy in the tumor microenvironment?\",\"answer\":\"Injectable hydrogels can create a supportive local microenvironment for CAR-T cells, enhancing survival, expansion, and effector function. They can also shield cells from hostile elements and enable controlled, site-specific delivery of cells, cytokines, or immunomodulatory compounds.\"}]","Bridging biomaterials and immunotherapy - hydrogel strategies for next-generation CAR-T cell treatment | PDF",1790127268,[145,149,153,157],{"page_no":8,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/abab19f376309686e12fbc6a05d63db7.webp",983,1310,{"page_no":14,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3871e9207d2685951bb587251c4e14b4.webp",982,1309,{"page_no":81,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f7a86d48eba84ae9170f12475d4ecd21.webp",981,1308,{"page_no":19,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f1d3a6cdf77aaedcb0d8e24b6026e6f5.webp",980,1306]